A UPLC-MS/MS Assay for Simultaneous Determination of Two Antipsychotics and Two Antidepressants in Human Plasma and Its Application in Clinic.
Antidepressants and antipsychotics are widely prescribed drugs for treatment of mental diseases. Therapeutic drug monitoring (TDM) is recommended for patients taking these drugs to ensure pharmaceutical efficacy, medication compliance and prevent toxicity. <p> Objective: A ultra-high performance liquid chromatography/tandem-mass spectrometry (UPLC-MS/MS) method was developed for simultaneous determination of two antidepressants-fluoxetine (FLU) and escitalopram (ESC), and two antipsychotics-risperidone (RIS) and aripiprazole (ARI), in human plasma. <p> Methods: Sample was processed by simple protein precipitation and the targeted analytes were separated on a C18 column by gradient elution with a mobile phase composing with 0.1% formic acid (v/v) and acetonitrile. All the analytes were qualitative and quantitative measured by electrospray ionization source with multiple reaction monitoring (MRM) in positive ion mode. Totally 56 plasma samples were obtained from out- or inpatients who were taking the cited four drugs for further analysis. <p> Results: The calibration curves for FLU, ESC, RIS and ARI were linear in the range of 45-1800, 4-320, 2-200 and 50-1800ng/mL, respectively. The entire analytical time for the analytes was 7.0 min for each run and the extraction efficiency was more than 90%. The sample was stable within various storage conditions. The trough concentrations in patients were measured with the validated method. <p> Conclusions: The developed method was successfully used to simultaneous determination of FLU, ESC, RIS and ARI in patients' plasma, which is with great clinic value for individual therapy.